Clinical Trial Update: Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial of cetuximab in patients with metastatic and/or locally advanced soft tissue and bony sarcomas has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2011-09-12